Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria

PHASE4CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Albuminuria
Interventions
DRUG

Ramipril + Irbesartan

Tablets + Capsules, Oral, 10mg Ramipril + 300mg Irbesartan target dose, Once daily, 20 weeks.

DRUG

Ramipril + Placebo

Tablets + Capsules, Oral, 10mg Ramipril + 300mg Placebo target dose, Once daily, 20 weeks.

Trial Locations (92)

Unknown

Local Institution, Tustin

Local Institution, Miami

Local Institution, West Palm Beach

Local Institution, Chicago

Local Institution, Flushing

Local Institution, New York

Local Institution, Cleveland

Local Institution, Philadelphia

Local Institution, Providence

Local Institution, San Antonio

Local Institution, Milwaukee

Local Institution, Burwood

Local Institution, Camperdown

Local Institution, Gosford

Local Institution, St Leonards

Local Institution, Woolloongabba

Local Institution, Box Hill

Local Institution, Fitzroy

Local Institution, Parkville

Local Institution, Fremantle

Local Institution, Edmonton

Local Institution, Vancouver

Local Institution, Winnipeg

Local Institution, Halifax

Local Institution, Scarborough Village

Local Institution, Toronto

Local Institution, Laval

Local Institution, Longueuil

Local Institution, Boulogne-sur-Mer

Local Institution, Colmar

Local Institution, Grenoble

Local Institution, Pessac

Local Institution, Strasbourg

Local Institution, Aschaffenburg

Local Institution, Bad Mergentheim

Local Institution, Göttingen

Local Institution, Halle

Local Institution, Künzing

Local Institution, München

Local Institution, Ornbau

Local Institution, Vellmar

Local Institution, Villingen-Schwenningen

Local Institution, Ashkelon

Local Institution, Beersheba

Local Institution, Hadera

Local Institution, Holon

Local Institution, Jerusalem

Local Institution, Kfar Saba

Local Institution, Kiryat Biyalik

Local Institution, Nazareth

Local Institution, Ramat Gan

Local Institution, Rehovot

Local Institution, Tel Aviv

Local Institution, Ẕerifin

Local Institution, Chieri

Local Institution, Genova

Local Institution, Lecco

Local Institution, Napoli

Local Institution, Rimini

Local Institution, Rome

Local Institution, San Benedetto del Tronto

Local Institution, Daugavpils

Local Institution, Riga

Local Institution, Kaunas

Local Institution, Klaipėda

Local Institution, Panevezys

Local Institution, Šiauliai

Local Institution, Vilnius

Local Institution, Aguascalientes

Local Institution, Guadalajara

Local Institution, Mexico City

Local Institution, Morelia

Local Institution, Monterrey

Local Institution, México

Local Institution, Amsterdam

Local Institution, Blaricum

Local Institution, Eindhoven

Local Institution, Groningen

Local Institution, Stadskanaal

Local Institution, Zeist

Local Institution, Zwolle

Local Institution, Moscow

Local Institution, Saint Petersburg

Local Institution, Barcelona

Local Institution, Jerez de la Frontera

Local Institution, Las Palmas de G. C.

Local Institution, Madrid

Local Institution, Marbella

Local Institution, Middlesbrough

Local Institution, Belfast

Local Institution, Birmingham

Local Institution, Derby

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY